3553 results for «2265»
3553 results
Innovative solutions to treat diabetic patients
Watch this video if you want to understand the need of dedicated DES for Diabetes Mellitus (DM) patients, to understand and learn the differences of CAD for diabetic compared to non-diabetic patients, to see clinical evidences and results for the treatment of Diabetic patients with DES+...
Addressing diabetes globally with an innovative solution
18 May 2021 – From EuroPCR 2021
Watch this session presented by Roxana Mehran, Luca Testa and Alexandre Abizaid in order to understand the need to address diabetes with a dedicated solution, to learn how the DES+DCB platform can help counter DM in PCI, and to get insights into the ongoing and upcoming clinical programs.
View...
Abluminus DES+: an innovative solution going global to beat diabetes
18 May 2021 – From EuroPCR 2021
Watch this session presented by Roxana Mehran, Luca Testa, Alexandre Abizaid and Marie-Claude Morice in order to know more about the need of a dedicated DES+ for diabetic patients and the technology behind it and the updates on ongoing and upcoming studies and trials, as well...
Transforming DCB strategy: sirolimus-coated balloon with Nanolute technology
21 May 2019 – From EuroPCR 2019
Consult this session on DCB strategy to learn more about the use of sirolimus-coated balloon with Nanolute technology, and to understand its benefits and its future applications in coronary interventions, thanks to the insight from pre-clinical evaluation, various clinical cases and FDA study.
DynamX Bioadaptor, the new frontier beyond stenting for PCI
22 May 2019 – From EuroPCR 2019
Consult this session on DynamX Bioadaptor to learn more about its technological advances and the early clinical trial results including QCA, IVUS and OCT imaging.
What's next in DES technology? Innovative DES platforms combining DES with DCB
19 May 2022 – From EUROPCR 2022
Via a series of case presentations, learn more about the dual drug delivery from DES and DCB platform to treat diabetes mellitus patients. Understand its efficiency in a complex setting and see how a no-polymer DES and DCB platform can fill the gaps of the unmet...
Zero-contrast TAVI while using a novel full-body embolic protection filter
26 Nov 2024 – From PCR London Valves 2024
Discover the latest advancements in zero-contrast TAVI through this case-based session. Learn when to consider a zero-contrast protocol, gain practical insights on performing the procedure, and explore a novel full-body embolic protection filter designed to enhance safety during transcatheter interventions.
360 management of cardiogenic shock
22 May 2025 – From EuroPCR 2025
This session presents a comprehensive 360-degree approach to managing cardiogenic shock, featuring long-term outcomes of low-profile ventricular assist devices, emergency ECMO implementation in PCI centers without on-site surgery, and pharmacologic strategies comparing cangrelor and ticagrelor efficacy and safety in acute myocardial infarction complicated by cardiogenic shock...
TAVI in challenging cases: pushing the limits
21 May 2025 – From EuroPCR 2025
Navigate challenging TAVI cases with this focused session emphasizing valve-in-valve procedures in complex anatomical scenarios. Learn strategies for managing TAVI in patients with multivessel disease and impaired ventricular function, and optimize procedural planning using advanced imaging, access methods, and device selection through detailed case presentations and...
Bioresorbable scaffold: new data, new hope?
22 May 2019 – From EuroPCR 2019
Consult this session on bioresorbable scaffold (BRS) to learn about new data and clinical outcomes: FAMTOM II trial, BIOSOLVE-IV registry, and more!
The next generation DES technology: innovative DES+DCB stent platform
Next generation of DES technology, what it's all about? Find out in this session where experts will present complex cases from around the world and discuss the new indications for which they can be used.
PCI in patients with diabetes: next generation DES + DCB stent platform in action
14 May 2024 – From EuroPCR 2024
Watch this session on PCI in diabetic patients to learn about a groundbreaking technology addressing the complexities of this critical subgroup. Discover the next-generation DES and DCB stent platform and the innovative Envisolution technology behind it. Understand how it works, its advantages in managing complex cases,...
Sirolimus-coated balloon: expanding the scope of indications for complex coronary artery disease treatment
14 May 2024 – From EuroPCR 2024
Watch this session to gain case-based insights on using DCBs in complex settings. Learn valuable tips and tricks for optimal DCB application, including the best timing and situations for their use. Discover how to effectively implement a hybrid strategy that combines DES and DCB when needed.
Stents in challenging situations
18 May 2022 – From EuroPCR 2022
Watch this session to discover the use and outcome of a selection of abstract submissions concerning: the treatment of diffuse CAD with one long stent vs. multistents, novel uncaging bioadaptor for coronary revascularisation, one-month DAPT in high bleeding risk ACS patients and much more.
TAVI innovations
27 Nov 2022 – From PCR London Valves 2022
Discover some of the latest innovations in TAVI presented at PCR LV 2022: zero-contrast TAVI, emerging technique for coronary protection in ViV TAVR, first dedicated splitting device in a degenerated TAVR at risk for double coronary obstruction, and much more!
Rapid-fire abstracts: Session 10
29 Nov 2022 – From PCR London Valves 2022
Discover a selection of abstracts presented during PCR LV 2022: trends in utilisation of percutaneous tricuspid valve vegetation debulking in endocarditis 2017-19, association of TRI-SCORE with clinical outcomes after transcatheter tricuspid valve repair, transcatheter edge-to-edge repair vs. percutaneous annuloplasty for tricuspid regurgitation, and more!
Ability to treat diabetic patients: DES + DCB strategy
23 May 2019 – From EuroPCR 2019
Consult this session to get insights about the need for a dedicated drug eluting stent (DES), as well as the benefits of a DES+DCB strategy, for diabetes mellitus (DM) and acute MI (AMI) patients.
The ability to transform coronary artery disease treatment: innovative nanotechnology-based sirolimus DES and DCB platforms
18 May 2022 – From EuroPCR 2022
Alexandre Abizaid, Marco Valgimigli, Fazila Malik, Luca Testa, Patrick W. Serruys, Damiano Regazzoli, Kumar Prathap, and Sandeep Basavarajaiah take turns in this session to discuss two innovative technologies: a stent platform with nanotechnology and a novel drug-coated balloon (DCB). These novel technologies both have unique features...
Hotline TAVI 1: extended analysis of the randomised trials
21 May 2025 – From EuroPCR 2025
Gain comprehensive insights from extended analyses of randomized TAVI trials. This session reviews five-year UK TAVI outcomes, cardiac damage evolution in asymptomatic aortic stenosis, one-year results from the LANDMARK trial, and three-year comparisons of balloon-expandable valves, highlighting critical clinical implications.
Active posterior leaflet replacement - A novel transcatheter approach for the treatment of primary and secondary mitral regurgitation
21 May 2025 – From EuroPCR 2025
Find out more about an innovative transcatheter strategy for managing both primary and secondary mitral regurgitation in this EuroPCR 2025 session. Experts introduce the concept of active posterior leaflet replacement and present the Polares MRace device—a novel solution designed to address the limitations of current therapies....
